CLINICAL_TRIALS
trial_result
· 2026-02-18
Clinical Trial Update: Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension [Phase 3]
Summary
A Phase 3 trial comparing monotherapy versus combination therapy for pediatric pulmonary arterial hypertension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Johns Hopkins University | Conditions: Pediatric Pulmonary Hypertension | Phase 3 | Status: COMPLETED